MUN HIN YONG
Sydney,Australia
Summary
Strategic Oncology Medical Affairs leader with expertise in global medical strategy and evidence generation. Drives collaboration between Medical Affairs and Clinical Development, enhancing global oncology programs through study design and feasibility assessments. Partners with stakeholders to translate pipeline science into effective medical strategies and lifecycle optimization. Builds trusted relationships with clinical experts, internal teams, and regulators.
Overview
17
17
years of professional experience
Work History
Therapeutic Area Medical Lead – Oncology
Amgen Australia Pty Ltd
02.2020 - Current
- Lead regional oncology medical strategy aligned with global franchise objectives, providing strategic medical input into pipeline and in-market assets across lung and gastrointestinal malignancies.
- Act as a strategic Medical Affairs partner to Global Clinical Development teams, contributing to protocol design, feasibility assessments and investigator engagement for Phase I–III studies.
- Serve as the primary medical interface between regional investigators and global teams, ensuring high-quality bidirectional scientific exchange.
- Lead and govern investigator-sponsored studies, ensuring scientific rigor, patient safety, compliance and operational feasibility.
- Drive launch readiness and lifecycle optimisation through close collaboration with commercial, regulatory, market access and safety teams.
- Coach and guide Medical Science Liaisons in regional scientific engagement planning and insight generation.
- Key Accomplishments - Interim Medical Director during parental leave, overseeing medical governance and strategic decision-making.
- Successful launch of multiple oncology products with strong scientific and clinical positioning.
- Led 3 investigator-sponsored studies from initiation to completion.
- Supported multiple Phase I–III global oncology trials through regional medical leadership and investigator engagement.
- Developed 47 regional medical assets (JAPAC) supporting congresses, medical education and scientific exchange.
Medical Advisor
Bayer Australia Pty Ltd
05.2018 - 02.2020
- Provided medical leadership across cardiovascular therapeutic areas in Australia and New Zealand.
- Supported clinical studies and post-marketing research through protocol input, feasibility assessment and investigator engagement.
- Delivered medico-marketing training and scientific support to regulatory and market access teams.
- Ensured compliance with Medicines Australia Code of Conduct.
- Key Accomplishments - Received 9 awards for leadership, flexibility and exceeding objectives.
- Recognised for strengthening medico-marketing impact and KOL engagement.
Associate Medical Director
Bayer (Malaysia, Singapore, Brunei)
02.2017 - 04.2018
- Oversaw medical affairs operations in Malaysia, supporting regulatory, pharmacovigilance and business development functions.
- Ensured compliance with PhAMA Malaysia Code of Conduct.
- Key Accomplishments - Accelerated team development, enabling global role progression for two team members.
- Led Malaysia’s award-winning Best Brand Plan team.
- Successfully defended Bayer Malaysia in a regulatory case against Boehringer Ingelheim.
Senior Medical Advisor / Medical Advisor – Oncology (Solid Tumours & Rare Diseases)
Novartis Corporation (Malaysia)
12.2014 - 01.2017
- Led medical education initiatives and scientific training for internal and external stakeholders.
- Collaborated with investigators on clinical trials across breast, lung and renal cancers.
- Managed access programs and supported lifecycle activities for oncology portfolios.
- Key Accomplishments - Launched a lung cancer product through strategic access programs and advisory boards.
- Successfully transitioned key oncology products from GSK to Novartis.
- Awarded Novartis Oncology Best Team (Rare Diseases) Award 2015.
Clinical Research Medical Advisor
Novartis (Malaysia)
07.2014 - 01.2015
- - Oversaw biosimilar trials across 10 sites with 90% recruitment and full compliance.
Medical Affairs Manager
Roche Pharmaceuticals (Malaysia)
07.2012 - 08.2013
- - Managed medical strategy across transplant, immunology, hepatitis, rheumatology and oncology.
- - Led scientific exchange meetings and advisory boards.
Medical Affairs Manager
Roche Pharmaceuticals (Malaysia)
03.2010 - 08.2011
- - Managed medical strategy across transplant, immunology, hepatitis, rheumatology and oncology.
- - Led scientific exchange meetings and advisory boards.
Medical Doctor
Hospital Ampang
02.2009 - 02.2011
- - Clinical rotations in Internal Medicine, Surgery, and Obstetrics & Gynaecology; Houseman leader.
Education
MBBS, MPH -
University of Dundee
ScotlandSkills
- Global & Regional Oncology Medical Strategy
- Clinical Development Interface (Phase I–III)
- Franchise & Lifecycle Planning
- Evidence Generation, Publications & Data Gaps
- Investigator-Sponsored Research (ISR/IIR)
- KOL Strategy, Mapping & Advisory Boards
- Cross-Functional & Matrix Leadership (Global–Regional–Local)
- Regulatory, Compliance & Medical Governance
- Medical Education, Congress & Scientific Communications
- Managed Access & Expanded Access Programs
- Digital & Omnichannel Medical Engagement
Awards
- Multiple leadership and performance awards at Amgen and Bayer for medical excellence and cross-functional impact.
- Novartis Oncology Best Team Award (2015).
- Novartis Oncology Spot Team Award (2016) for innovative digital medical initiatives.
Accomplishments
- 15+ years of global and regional medical affairs leadership experience in oncology across top-tier pharmaceutical organisations (Amgen, Bayer, Novartis, Roche).
- Drove regional (JAPAC/APAC) and country-level oncology medical strategy aligned with global franchise and clinical development priorities.
- Core contributor to Phase I–III global oncology programs through protocol review, feasibility assessment, investigator engagement and scientific input into study design.
- Led medical strategy and lifecycle planning for multiple oncology launches across lung, GI, breast, renal and rare cancers.
- Led 3 investigator-sponsored studies end-to-end and supported multiple global trials across early and late phases.
- Interim Medical Director leadership, overseeing medical governance, compliance and cross-functional decision-making.
- Developed and governed 47 high-impact regional medical assets (JAPAC) supporting scientific communication, medical education and congress strategy.
Oncology And Clinical Development Experience
Lung, gastrointestinal, breast, renal, multiple myeloma, rare cancers, Targeted therapies, solid tumours, rare oncology indications, Phase I, Ib/II, II, III, Global interventional trials, investigator-sponsored studies, observational studies, managed access programs, Study design input, feasibility strategy, protocol review, investigator engagement, regional study support
Core Expertise
- Global & Regional Oncology Medical Strategy
- Clinical Development Interface (Phase I–III)
- Franchise & Lifecycle Planning
- Evidence Generation, Publications & Data Gaps
- Investigator-Sponsored Research (ISR/IIR)
- KOL Strategy, Mapping & Advisory Boards
- Cross-Functional & Matrix Leadership (Global–Regional–Local)
- Regulatory, Compliance & Medical Governance
- Medical Education, Congress & Scientific Communications
- Managed Access & Expanded Access Programs
- Digital & Omnichannel Medical Engagement
Languages
English
Professional
Cantonese
Professional
Malay
Professional
Mandarin
Limited
Timeline
Therapeutic Area Medical Lead – Oncology
Amgen Australia Pty Ltd
02.2020 - Current
Medical Advisor
Bayer Australia Pty Ltd
05.2018 - 02.2020
Associate Medical Director
Bayer (Malaysia, Singapore, Brunei)
02.2017 - 04.2018
Senior Medical Advisor / Medical Advisor – Oncology (Solid Tumours & Rare Diseases)
Novartis Corporation (Malaysia)
12.2014 - 01.2017
Clinical Research Medical Advisor
Novartis (Malaysia)
07.2014 - 01.2015
Medical Affairs Manager
Roche Pharmaceuticals (Malaysia)
07.2012 - 08.2013
Medical Affairs Manager
Roche Pharmaceuticals (Malaysia)
03.2010 - 08.2011
Medical Doctor
Hospital Ampang
02.2009 - 02.2011
MBBS, MPH -
University of Dundee